POWERPLAY Phase 2: Development and Evaluation in Male-dominated Workplaces

POWERPLAY: Building Employee Health and Safety Through Prevention in Male-dominated Workplaces

With funding from the Alberta Ministry of Labour (Grant #095244772), a program called POWERPLAY (www.powerplayatwork.com), designed to promote men's health at work, will be evaluated in workplaces in Alberta.

Study Overview

• Status: Completed
• Conditions: Mental Health Wellness 1; Health Behavior; Health Knowledge, Attitudes, Practice; Men
• Intervention / Treatment: Behavioral: POWERPLAY

Detailed Description

In year 1, this project includes two main research components: 1. A pragmatic (real world) study will be conducted employing a quasi-experimental (not a randomized controlled trial), before and after design to evaluate the effectiveness of the POWERPLAY program. 2. An integrated set of research activities (systematic review, sleep behaviors and consultation groups) will be used to provide the basis for developing recommendations for promoting sleep health in male-dominated workplaces, and inform the development and testing of a POWERPLAY sleep health module (REST-UP) in Year 2.

• Study Type: Interventional
• Enrollment (Actual): 498
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Canada
  • Alberta
    • Fort Saskatchewan, Alberta, Canada, T8L 4A4
      • Shell Canada Ltd (Scotford Site)
    • Rocky Mountain House, Alberta, Canada, T4C 1B2
      • Roper Ventures
  • British Columbia
    • Prince George, British Columbia, Canada, V2N 2S6
      • PeroxyChem

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: Male

Description

Inclusion Criteria:

• Men employed in participating workplaces, full-time or part-time, in any position within the organizations.

Exclusion Criteria:

• Although females may participate in the POWERPLAY program and surveys, they will not be included in the evaluation.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Non-Randomized
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Moderate to Vigorous Physical Activity	Minutes of Moderate to Vigorous physical activity will be assessed using self-report at baseline and follow-up using the Godin Leisure-Time Exercise Questionnaire (Godin & Shephard, 1985). The Godin Leisure-Time Exercise Questionnaire contains three self-report questions that assess both the average frequency and duration (in minutes) of mild, moderate, and vigorous activities during free time over a typical week. Frequency and minutes are multiplied to obtain minutes per week (range from 0 and up). Weekly moderate and vigorous activity minutes will be summed and compared from baseline to follow-up, with higher scores indicating more activity. In addition, a cutoff of 150 minutes in 7 days will be used to classify participants as meeting or not meeting Canadian guidelines for physical activity at baseline and follow-up.	4 months
Mental Wellness	Mental well-being will be assessed using the well validated Short Warwick-Edinburgh Mental Well-Being Scale (SWEMWBS) (Haver, Akerjordet, Caputi, Furunes, & Magee, 2015; Tennant et al., 2007) at baseline and follow-up. Participants respond to 7-items (e.g., "I've been feeling optimistic about the future") on a 5-point Likert scale ranging from none of the time (1) to all of the time (5), with higher scores reflecting greater mental well-being. The SWEMWBS is scored by summing the score for each of the seven items (possible range 7-35).	4 months

Collaborators and Investigators

• Sponsor: Joan Bottorff
• Collaborators: University of British Columbia; University of Alberta; Newcastle University; Athabasca University; University of Melboune; University Technology Sydney

Publications and helpful links

Helpful Links

• POWERPLAY program website

Study record dates

Study Major Dates

• Study Start (Actual): April 1, 2019
• Primary Completion (Actual): February 7, 2020
• Study Completion (Actual): February 7, 2020

Study Registration Dates

• First Submitted: December 18, 2018
• First Submitted That Met QC Criteria: December 18, 2018
• First Posted (Actual): December 19, 2018

Study Record Updates

• Last Update Posted (Actual): April 8, 2020
• Last Update Submitted That Met QC Criteria: April 6, 2020
• Last Verified: April 1, 2020

More Information

Terms related to this study

• Other Study ID Numbers: 095244772

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No